Joshua Waitzman
Senior Medical Director Vera Therapeutics
Seminars
Thursday 20th August 2026
Roundtable Discussion: Integrating Human Evidence & Translational Models with AI to Improve Target Identification
2:00 pm
- Where are organizations successfully integrating AI from early discovery through to clinical validation?
- What challenges remain in applying AI to integrate translational model data with human clinical and real-world datasets
- How can AI-driven insights be validated and translated into confident decisions when advancing targets into clinical development?
Thursday 20th August 2026
Maximizing Asset Value in Rare Kidney Disease: Expanding from IgA to New Indications & Designing Proof-of-Concept Trials to Accelerate Development
9:30 am
- Leveraging clinical success in one indication to de-risk expansion into new rare kidney diseases
- Designing efficient proof-of-concept trials in small, heterogeneous patient populations
- Aligning indication expansion strategies with regulatory expectations and endpoint selection
- Balancing speed, cost, and probability of success when advancing pipeline-in-aproduct strategies
